Cargando…
The impact of tumor burden at the initial hepatectomy on the recurrence-to-death survival after repeat surgical resection/radiofrequency ablation: a retrospective study
BACKGROUND: Previous studies have reported the surgical resection (SR) and radiofrequency ablation (RFA) could achieve comparable recurrence-to-death survival (RTDS). However, the impact of primary tumor burden on RTDS of patients with recurrent hepatocellular carcinoma (HCC) following SR or RFA has...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118788/ https://www.ncbi.nlm.nih.gov/pubmed/35585534 http://dx.doi.org/10.1186/s12893-022-01643-7 |
_version_ | 1784710573174292480 |
---|---|
author | Wu, Youwei Peng, Wei Shen, Junyi Zhang, Xiaoyun Li, Chuan Wen, Tianfu |
author_facet | Wu, Youwei Peng, Wei Shen, Junyi Zhang, Xiaoyun Li, Chuan Wen, Tianfu |
author_sort | Wu, Youwei |
collection | PubMed |
description | BACKGROUND: Previous studies have reported the surgical resection (SR) and radiofrequency ablation (RFA) could achieve comparable recurrence-to-death survival (RTDS). However, the impact of primary tumor burden on RTDS of patients with recurrent hepatocellular carcinoma (HCC) following SR or RFA has not been clarified. METHODS: From January 2009 to March 2015, 171 patients who underwent initial hepatectomy and second curative treatments in West China Hospital were retrospectively analyzed. Survival analysis was performed by the Kaplan–Meier method. Risk factors were identified using the Cox proportional hazard model. RESULTS: At initial hepatectomy, 96 patients (56.1%) were diagnosed with HCC within the Milan criteria (MC), and 75 patients (43.9%) were HCC beyond the MC. The clinicopathological features and re-treatment methods of recurrent HCC were similar between patients with primary HCC within or beyond the MC. Patients with primary HCC within the MC had longer recurrence time (31.4 ± 24.2 months vs. 20.2 ± 16 months, P < 0.001). The 1- and 3- year RTDS within and beyond the MC group were 88.8%, 57.6% and 79.0%, 46.3%, respectively (P = 0.093). In multivariate analysis, the recurrence time, tumor size and AFP > 400 ng/mL at the time of recurrence were associated with RTDS. CONCLUSIONS: The primary tumor burden had no impact on RTDS, but had an impact on recurrence time. The recurrence time had an impact on RTDS and might be a good index to reflect the biology of recurrent HCC. |
format | Online Article Text |
id | pubmed-9118788 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-91187882022-05-20 The impact of tumor burden at the initial hepatectomy on the recurrence-to-death survival after repeat surgical resection/radiofrequency ablation: a retrospective study Wu, Youwei Peng, Wei Shen, Junyi Zhang, Xiaoyun Li, Chuan Wen, Tianfu BMC Surg Research BACKGROUND: Previous studies have reported the surgical resection (SR) and radiofrequency ablation (RFA) could achieve comparable recurrence-to-death survival (RTDS). However, the impact of primary tumor burden on RTDS of patients with recurrent hepatocellular carcinoma (HCC) following SR or RFA has not been clarified. METHODS: From January 2009 to March 2015, 171 patients who underwent initial hepatectomy and second curative treatments in West China Hospital were retrospectively analyzed. Survival analysis was performed by the Kaplan–Meier method. Risk factors were identified using the Cox proportional hazard model. RESULTS: At initial hepatectomy, 96 patients (56.1%) were diagnosed with HCC within the Milan criteria (MC), and 75 patients (43.9%) were HCC beyond the MC. The clinicopathological features and re-treatment methods of recurrent HCC were similar between patients with primary HCC within or beyond the MC. Patients with primary HCC within the MC had longer recurrence time (31.4 ± 24.2 months vs. 20.2 ± 16 months, P < 0.001). The 1- and 3- year RTDS within and beyond the MC group were 88.8%, 57.6% and 79.0%, 46.3%, respectively (P = 0.093). In multivariate analysis, the recurrence time, tumor size and AFP > 400 ng/mL at the time of recurrence were associated with RTDS. CONCLUSIONS: The primary tumor burden had no impact on RTDS, but had an impact on recurrence time. The recurrence time had an impact on RTDS and might be a good index to reflect the biology of recurrent HCC. BioMed Central 2022-05-18 /pmc/articles/PMC9118788/ /pubmed/35585534 http://dx.doi.org/10.1186/s12893-022-01643-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Wu, Youwei Peng, Wei Shen, Junyi Zhang, Xiaoyun Li, Chuan Wen, Tianfu The impact of tumor burden at the initial hepatectomy on the recurrence-to-death survival after repeat surgical resection/radiofrequency ablation: a retrospective study |
title | The impact of tumor burden at the initial hepatectomy on the recurrence-to-death survival after repeat surgical resection/radiofrequency ablation: a retrospective study |
title_full | The impact of tumor burden at the initial hepatectomy on the recurrence-to-death survival after repeat surgical resection/radiofrequency ablation: a retrospective study |
title_fullStr | The impact of tumor burden at the initial hepatectomy on the recurrence-to-death survival after repeat surgical resection/radiofrequency ablation: a retrospective study |
title_full_unstemmed | The impact of tumor burden at the initial hepatectomy on the recurrence-to-death survival after repeat surgical resection/radiofrequency ablation: a retrospective study |
title_short | The impact of tumor burden at the initial hepatectomy on the recurrence-to-death survival after repeat surgical resection/radiofrequency ablation: a retrospective study |
title_sort | impact of tumor burden at the initial hepatectomy on the recurrence-to-death survival after repeat surgical resection/radiofrequency ablation: a retrospective study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118788/ https://www.ncbi.nlm.nih.gov/pubmed/35585534 http://dx.doi.org/10.1186/s12893-022-01643-7 |
work_keys_str_mv | AT wuyouwei theimpactoftumorburdenattheinitialhepatectomyontherecurrencetodeathsurvivalafterrepeatsurgicalresectionradiofrequencyablationaretrospectivestudy AT pengwei theimpactoftumorburdenattheinitialhepatectomyontherecurrencetodeathsurvivalafterrepeatsurgicalresectionradiofrequencyablationaretrospectivestudy AT shenjunyi theimpactoftumorburdenattheinitialhepatectomyontherecurrencetodeathsurvivalafterrepeatsurgicalresectionradiofrequencyablationaretrospectivestudy AT zhangxiaoyun theimpactoftumorburdenattheinitialhepatectomyontherecurrencetodeathsurvivalafterrepeatsurgicalresectionradiofrequencyablationaretrospectivestudy AT lichuan theimpactoftumorburdenattheinitialhepatectomyontherecurrencetodeathsurvivalafterrepeatsurgicalresectionradiofrequencyablationaretrospectivestudy AT wentianfu theimpactoftumorburdenattheinitialhepatectomyontherecurrencetodeathsurvivalafterrepeatsurgicalresectionradiofrequencyablationaretrospectivestudy AT wuyouwei impactoftumorburdenattheinitialhepatectomyontherecurrencetodeathsurvivalafterrepeatsurgicalresectionradiofrequencyablationaretrospectivestudy AT pengwei impactoftumorburdenattheinitialhepatectomyontherecurrencetodeathsurvivalafterrepeatsurgicalresectionradiofrequencyablationaretrospectivestudy AT shenjunyi impactoftumorburdenattheinitialhepatectomyontherecurrencetodeathsurvivalafterrepeatsurgicalresectionradiofrequencyablationaretrospectivestudy AT zhangxiaoyun impactoftumorburdenattheinitialhepatectomyontherecurrencetodeathsurvivalafterrepeatsurgicalresectionradiofrequencyablationaretrospectivestudy AT lichuan impactoftumorburdenattheinitialhepatectomyontherecurrencetodeathsurvivalafterrepeatsurgicalresectionradiofrequencyablationaretrospectivestudy AT wentianfu impactoftumorburdenattheinitialhepatectomyontherecurrencetodeathsurvivalafterrepeatsurgicalresectionradiofrequencyablationaretrospectivestudy |